RPGLIFE vs WINDLAS: Stock Comparison

RPG LIFE SCIENCES vs WINDLAS BIOTECHUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

RPG LIFE SCIENCES is the larger company by market capitalisation. RPG LIFE SCIENCES shows a higher ROE, a higher dividend yield and faster revenue growth, while WINDLAS BIOTECH shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

RPGLIFE leads 8; WINDLAS leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

RPGLIFEWINDLAS

Valuation lens

What price are you paying?

Market CapContext only
₹4,515 Cr
₹2,310 Cr
P/E RatioWINDLAS has the lower reading
51.42x
43.22x
P/B RatioWINDLAS has the lower reading
7.03x
3.63x
EPSRPGLIFE has the higher reading
₹18.6
₹8.55
Book ValueContext only
₹366.03
₹281.47
Dividend YieldRPGLIFE has the higher reading
0.91%
0.64%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RPGLIFE is the larger company
₹4,515 Cr vs ₹2,310 Cr
P/E Ratio
WINDLAS has a lower P/E
43.22x vs 51.42x
P/B Ratio
WINDLAS has a lower P/B
3.63x vs 7.03x
EPS
RPGLIFE has higher earnings per share
₹18.6 vs ₹8.55
Dividend Yield
RPGLIFE has a higher dividend yield
0.91% vs 0.64%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs 17.7%
EPS Growth (TTM YoY)
WINDLAS has faster EPS growth
-2.6% vs -74.5%
Qtr Sales Growth
WINDLAS has stronger quarterly sales growth
4.03% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricRPGLIFEWINDLAS
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricRPGLIFEWINDLAS
Live Price₹2,721.6₹1,126.35
Day Change2.61%-0.07%
Volume20,4631.91 L
52-Week High₹3,082₹1,148
52-Week Low₹1,733₹697.4
Distance from 52W High-11.69%-1.89%

Valuation

MetricRPGLIFEWINDLAS
Market Cap₹4,515 Cr₹2,310 Cr
P/E Ratio51.42x43.22x
P/B Ratio7.03x3.63x
EPS₹18.6₹8.55
Book Value₹366.03₹281.47
Dividend Yield0.91%0.64%

Growth

MetricRPGLIFEWINDLAS
Revenue Growth (TTM YoY)23.6%17.7%
EPS Growth (TTM YoY)-74.5%-2.6%
Qtr Sales Growth0%4.03%
Qtr Profit Growth0.62%10.4%

Profitability & Leverage

MetricRPGLIFEWINDLAS
ROE19.02%11.44%
ROCE24.39%11.95%
Net Margin29.25%7.35%
Operating Margin21.92%10.15%
Debt to Equity0.03x0.05x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricRPGLIFEWINDLAS
Promoter Holding72.95%63.31% 1.41 pp
FII Holding0.95% 0.08 pp2.04% 1.44 pp
DII Holding8.67% 1.22 pp9.84% 1.97 pp
Public Holding17.42% 1.31 pp24.8% 0.9 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: RPG LIFE SCIENCES and WINDLAS BIOTECH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.